ENLON (edrophonium chloride)
DIAGNOSTIC TEST FOR MYASTHENIA GRAVIS·+2
BIONICHE PHARMA
Indication
Diagnostic test for myasthenia gravis
A diagnostic test for myasthenia gravis is an evaluative procedure indicated to confirm or aid in the differential diagnosis of myasthenia gravis in individuals presenting with unexplained skeletal muscle weakness. Read more about Diagnostic test for myasthenia gravis
1 drugs 1 manufacturers
Drugs that treat it
Common Diagnostic test for myasthenia gravis therapies.
Filter & compare in the drug finder →Opens the drug finder with Diagnostic test for myasthenia gravis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA diagnostic test for myasthenia gravis is an evaluative procedure indicated to confirm or aid in the differential diagnosis of myasthenia gravis in individuals presenting with unexplained skeletal muscle weakness.
Myasthenia gravis is a chronic autoimmune neuromuscular junction disorder characterized by antibody-mediated destruction or blockade of functional components—most commonly acetylcholine receptors—at the postsynaptic motor endplate.
This disrupted transmission causes fluctuating, fatigable weakness in voluntary muscle groups, characteristically involving ocular muscles (manifesting as ptosis and diplopia) as well as bulbar, facial, axial, limb, or respiratory musculature that worsens with exertion and improves with rest.
- fda.gov
A diagnostic test for myasthenia gravis is an evaluative procedure indicated to confirm or aid in the differential diagnosis of myasthenia gravis in individuals presenting with unexplained skeletal muscle weakness
- mayoclinic.org
A diagnostic test for myasthenia gravis is an evaluative procedure indicated to confirm or aid in the differential diagnosis of myasthenia gravis in individuals presenting with unexplained skeletal muscle weakness
- nih.gov
Myasthenia gravis is a chronic autoimmune neuromuscular junction disorder characterized by antibody-mediated destruction or blockade of functional components—most commonly acetylcholine receptors—at the postsynaptic motor endplate
- ajmc.com
Myasthenia gravis is a chronic autoimmune neuromuscular junction disorder characterized by antibody-mediated destruction or blockade of functional components—most commonly acetylcholine receptors—at the postsynaptic motor endplate
- medlineplus.gov
Myasthenia gravis is a chronic autoimmune neuromuscular junction disorder characterized by antibody-mediated destruction or blockade of functional components—most commonly acetylcholine receptors—at the postsynaptic motor endplate This disrupted transmission causes fluctuating, fatigable weakness in voluntary muscle groups, characteristically involving ocular muscles (manifesting as ptosis and diplopia) as well as bulbar, facial, axial, limb, or respiratory musculature that worsens with exertion...
- nih.gov
This disrupted transmission causes fluctuating, fatigable weakness in voluntary muscle groups, characteristically involving ocular muscles (manifesting as ptosis and diplopia) as well as bulbar, facial, axial, limb, or respiratory musculature that worsens with exertion and improves with rest
Personalize your experience
Follow Diagnostic test for myasthenia gravis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.